Joint Canada-Israel Health Research Program
The Joint Canada-Israel Health Research Program (JCIHRP) is a seven-year, CAD35-million partnership between the International Development Research Centre (IDRC), the Azrieli Foundation, the Canadian Institutes of Health Research (CIHR) and the Israel Science Foundation (ISF) that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine. The program will fund 30 collaborative projects involving researchers from Canada and Israel, as well as collaborators from low- and middle-income countries.
Projects to be funded through this year’s competition (Neurobiology) will add to the 18 joint projects selected through the first three calls for proposals:
- 1st call (2015) – Neuroscience
- 2nd call (2016) – Immunology
- 3rd call (2017) – Cancer
- 4th call (2018) – Neurobiology (see the list of funded projects below)
- 5th call (2019) – Metabolism
Selected neurobiology research projects
The burden of neurological disorders has increased substantially over the past 25 years. For example, the expanded list of neurological conditions makes them the leading cause group of disability and the second-leading cause group of mortality worldwide. Furthermore, ongoing demographic changes in low and middle-income countries, such as lower child mortality rates and increases in aging populations, mean that the global number of patients needing neurological care will continue to grow. As such, additional research is critical to advancing our knowledge of the basic neurological mechanisms underlying neurological disorders. It is only with this evidence that we can design adequate services and therapeutic interventions.
The call for research proposals in the field of neurobiology was launched In October 2017. The proposals were evaluated by an international committee of 14 experts from eight countries, chaired by Professor Joshua Sanes from the Center for Brain Science at Harvard University. Six world-class teams were selected from among 45 proposals and will receive funding totaling up to CAD7 million over the next three years.
The following list of selected projects is in alphabetical order according to the Canadian nominated principal investigator's surname.
Researchers: Keith Murai (McGill University, Canada); Inbal Goshen (Hebrew University of Jerusalem, Israel); Shu-min Duan (Zhejiang University, China); Marcelo Chacon and Yorka Munoz (Universidad de Chile)
Researchers: Christopher Pack (McGill University, Canada); Ehud Zohary (Hebrew University of Jerusalem, Israel); Sujaya Neupane, Srijana Adhikary, and Keepa Vaidya (Tilganga Institute of Ophthalmology, Nepal)
Researchers: Adrien Peyrache (McGill University, Canada); Eran Stark (Tel-Aviv University, Israel); Mariano Belluscio and Daniela Piña Novo (Universidad de Buenos Aires, Argentina); Hugo Merchant (Univerisidad National Autonoma de Mexico)
- Deciphering the blueprint of healthy and diseased human brain through the generation of patterned cerebral organoids
Researchers: Carol Schuurmans (Sunnybrook Research Institute, Canada); Orly Reiner (Weizmann Institute of Science, Israel); Shubah Tole (Tata Institute of Fundamental Research, India)
Researchers: Melanie Woodin (University of Toronto, Canada); Adi Mizrahi (Hebrew University of Jerusalem, Israel); Antonia Marin-Burgin (Instituto de Investigación en Biomedicina, Argentina)
Researchers: Gerald Zamponi (University of Calgary, Canada); Alexander Binshtok (Hebrew University of Jerusalem, Israel); Juliana Chichorro and Erika Araya (Universidade Federal Do Parana, Brazil)